Kyung-Mi An - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kyung-Mi An

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Implant Dentistry|June 5, 2010

Comparative histomorphometric analysis of maxillary sinus augmentation with and without bone grafting in rabbitDong-Seok Sohn, Woo-Sung Kim, Kyung-Mi An, et al.

European Journal of Pharmacology|September 13, 2025

YN1548: A novel small-molecule agonist of human glucagon-like peptide-1 receptor for the treatment of type 2 diabetes mellitus and obesityIn-Gyu Je, Tae-Kwang Kim, Hyeong Jun Lee, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 28, 2024

Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetesJongmin Yoon, Don-Gil Lee, Haengjin Song, et al.

Bioorganic & Medicinal Chemistry Letters|May 14, 2016

Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteriaHee-Yeol Lee, Kyung-Mi An, Juyoung Jung, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 13, 2024

Lower hepatotoxicity risk in Xelaglifam, a novel GPR40 agonist, compared to Fasiglifam for type 2 diabetes therapyJongmin Yoon, Haengjin Song, Ji Soo Park, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Implant Dentistry|June 5, 2010

Comparative histomorphometric analysis of maxillary sinus augmentation with and without bone grafting in rabbitDong-Seok Sohn, Woo-Sung Kim, Kyung-Mi An, et al.

European Journal of Pharmacology|September 13, 2025

YN1548: A novel small-molecule agonist of human glucagon-like peptide-1 receptor for the treatment of type 2 diabetes mellitus and obesityIn-Gyu Je, Tae-Kwang Kim, Hyeong Jun Lee, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 28, 2024

Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetesJongmin Yoon, Don-Gil Lee, Haengjin Song, et al.

Bioorganic & Medicinal Chemistry Letters|May 14, 2016

Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteriaHee-Yeol Lee, Kyung-Mi An, Juyoung Jung, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 13, 2024

Lower hepatotoxicity risk in Xelaglifam, a novel GPR40 agonist, compared to Fasiglifam for type 2 diabetes therapyJongmin Yoon, Haengjin Song, Ji Soo Park, et al.

Pageof 2